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Which prosthetic foot to prescribe? Biomechanical differences found during a single 1 
session comparison of different foot types hold true one year later. 2 
 3 
Abstract 4 
Introduction: Clinicians typically use findings from cohort studies to objectively inform 5 
judgements regarding the potential (dis)advantages of prescribing a new prosthetic 6 
device. However, before finalising prescription a clinician will typically ask a patient to 7 
‘try out’ a change of prosthetic device while the patient is at the clinic. Observed 8 
differences in gait when using the new device should be the result of the device’s 9 
mechanical function, but could also conceivably be due to patient related factors which 10 
can change from day-to-day and can thus make device comparisons unreliable. To 11 
determine whether a device’s mechanical function consistently has a more meaningful 12 
impact on gait than patient-related factors, the present study undertook quantitative gait 13 
analyses of a trans-tibial amputee walking using two different foot-ankle devices on two 14 
occasions over a year apart. If the observed differences present between devices, 15 
established using quantitative gait analysis, were in the same direction and of similar 16 
magnitude on each of the two occasions, this would indicate that device-related factors 17 
were more important than patient-related factors. 18 
2 
 
 
Methods: One adult male with a unilateral trans-tibial amputation completed repeated 19 
walking trials using two different prosthetic foot devices on two separate occasions, 14 20 
months apart. Walking speed and sagittal plane joint kinematics and kinetics for both 21 
limbs were assessed on each occasion. Clinically meaningful differences in these 22 
biomechanical outcome variables were defined as those with an effect size difference 23 
(d) between prosthetic conditions of at least 0.4 (i.e. ‘medium’ effect size).  24 
Results: Eight variables namely, walking speed, prosthetic ‘ankle’ peak plantar- and 25 
dorsi-flexion and peak positive power, and residual knee loading response flexion, peak 26 
stance-phase extension and flexion moments and peak negative power, displayed 27 
clinically meaningful differences (d > 0.4) between foot devices during the first session. 28 
All eight of these showed similar effect size differences during the second session 29 
despite the participant being heavier and older. 30 
Conclusions: Findings suggest that a prosthetic device’s mechanical function 31 
consistently has a more meaningful impact on gait than patient-related factors. These 32 
findings support the current clinical practice of making decisions regarding prosthetic 33 
prescription for an individual, based on a single session evaluation of their gait using 34 
two different devices. However, to confirm this conclusion, a case series using the same 35 
approach as the present study could be undertaken. 36 
 37 
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 40 
Introduction  41 
Within a research setting, the efficacy of a particular prosthetic device is 42 
typically determined by comparing group mean biomechanical outcome variables (e.g. 43 
peak residual knee flexion during stance) from a cohort of lower-limb amputees 44 
performing locomotor tasks when using one device versus using a different device, 45 
typically with  differing design features1-8. Findings from such research is used by 46 
clinicians to objectively inform judgements regarding the potential (dis)advantages of 47 
prescribing one prosthetic device compared to another. Interpreting the findings from 48 
research in this way is based upon the assumption that the differences in biomechanical 49 
outcome variables between prosthetic conditions are solely a result of the prosthetic 50 
components and that the observed effect would be present for any patient with a similar 51 
level of amputation, activity level and health status as those reported in the research. 52 
However, this assumption may not necessarily be valid and even if it is, the 53 
applicability of such research findings to a clinical setting, where decisions regarding 54 
prosthetic prescription are made on a patient by patient basis, is questionable. For 55 
example, in a cohort study comparing the efficacy of one prosthetic device versus 56 
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another, it is entirely possible that group mean biomechanical outcome variables may 57 
indicate a statistically significant effect in one direction, even though some members of 58 
the group display minimal changes, or even changes in the opposing direction. Based on 59 
the findings from such studies, a clinician could make an evidence-based decision 60 
regarding prosthetic prescription that may have a negative outcome for a patient. 61 
Accordingly, before finalising prosthesis prescription, clinicians will typically ask a 62 
patient to ‘try out’ any recommended change in prosthetic device while the patient is at 63 
their clinic, with the necessary adjustments to alignment and the like being made with a 64 
view to optimising the device’s function during gait. Any differences in gait observed at 65 
the clinic when the patient switches to using the new device are expected to, and may 66 
indeed, be a result of the function of the new prosthetic device. However, it is possible 67 
that evaluation of a patient’s gait made on any day can also be affected by patient-68 
related factors (e.g. weight, physical condition, motivation) rather than soley device-69 
related factors alone. 70 
 71 
Therefore, in order to investigate the efficacy of carrying out such single-session 72 
evaluations, the current study undertook quantitative gait analyses of an individual with 73 
a trans-tibial amputation when using two different foot-ankle devices, on two separate 74 
occasions 14 months apart. It was reasoned that if quantitative gait analysis showed that 75 
the differences observed when using one device compared to the other were in the same 76 
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direction and of similar magnitude on each of the two occasions, this would indicate 77 
that device-related factors were more important than patient-related factors. This would 78 
highlight that a single-session qualitative comparison of an amputee’s gait using two 79 
different foot-ankle devices, as typically occurs in a clinic, is a valid approach in 80 
finalising descisions regarding prosthetic prescription, and, furthermore, that prosthetic 81 
prescription decisions should not be made solely using evidence from research 82 
evaluating group mean response to using a new device. 83 
 84 
Methods 85 
One healthy adult male (age 35.8 years, mass 90.4 kg, height 1.86 m at the time 86 
of the first data collection session) with a unilateral trans-tibial amputation, and 87 
described as being K4 on the Medicare Scale by his prescribing clinician, participated. 88 
Amputation of the right limb had been conducted, as a result of trauma, 9.2 years prior 89 
to the first data collection session. The habitual prosthetic foot device (at the time of 90 
both data collection sessions) was an Echelon VT (Chas. A Blatchford and Sons Ltd., 91 
Basingstoke, UK). The participant had used a full-contact, suction socket with silicon 92 
liner for 12 months prior to the first data collection session, and was using the same at 93 
the time of the second data collection session. Data were recorded while the participant 94 
completed repeated walking trials using two different types of prosthetic feet. A second, 95 
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identical data collection session was conducted 14 months later (at which time the 96 
participant’s mass had increased by 6.0 kg). The study gained ethical approval from the 97 
University of Bradford’s bioethics committee, with written informed consent being 98 
obtained from the participant prior to participation.  99 
 100 
In the present study, the protocol, trial order, laboratory set up, experimenters 101 
and prosthetist were identical for both data collection sessions. Segmental kinematic 102 
and ground reaction force data were recorded at 200 Hz using a ten camera motion 103 
capture system (Vicon MX, Oxford, UK) and two floor mounted force platforms 104 
(AMTI, Watertown, MA, USA) while the participant completed overground walking 105 
trials along a flat and level 8 m walkway (full details of the marker configuration used 106 
to determine segmental kinematics are reported in De Asha et al., 9). The participant 107 
completed 12 walking trials at a self-selected walking speed, using each of two 108 
prosthetic foot devices (details below) with stance phase kinetic data being recorded for 109 
the intact and prosthetic limbs (six trials for each limb in each prosthetic condition; 24 110 
trials in total). 111 
 112 
 To avoid habituation affecting the comparisons made between prosthetic feet, 113 
during both data collection sessions the participant used foot devices (an Elan and 114 
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Epirus; both Chas. A Blatchford and Sons Ltd., Basingstoke, UK) which were different 115 
from his currently prescribed foot. Both the Elan and Epirus feet incorporate a dynamic-116 
response foot base with the same shape and design of heel and fore-foot keels and both 117 
have an ankle device that passively articulates during stance. In both feet, deflection of 118 
the heel and forefoot keels provides simulated 'ankle' motion, with actual articulation 119 
occurring at the ankle device, which in the Elan is governed by a microprocessor 120 
controlled hydraulic unit, while in the Epirus it is governed by the elastic resistance 121 
offered by a rubber ball-joint. The overall prosthesis length, socket and suspension were 122 
unchanged between devices. However, as it was impossible to replicate exactly the foot 123 
alignment of the first data collection during the second, it was decided to use the same 124 
approach to obtain ‘optimal’ alignment for each foot at each session. Thus, as is 125 
common practice clinically, foot alignment was decided upon by a mixture of feedback 126 
regarding perceived function and comfort from the participant and the expertise of the 127 
prosthetist. After each foot device had been fitted the participant walked on it for a 128 
period of approximately 20 minutes prior to data collection to enable the participant to 129 
become accustomed to it. 130 
 131 
Initial processing of marker trajectories were undertaken within Nexus software 132 
(Vicon, Oxford, UK). Marker trajectory and ground reaction force data were then 133 
exported in C3D format to Visual 3D software (C-Motion, Germantown, MD, USA), 134 
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where it was then filtered using a fourth-order, zero-lag Butterworth filter with a 6 Hz 135 
cut-off, and all further processing was completed (for more details regarding data 136 
processing see De Asha et al. 9). Walking speed and sagittal plane joint kinematics and 137 
kinetics for both limbs have been shown by previous research to be important outcome 138 
variables in unilateral amputee gait10. Therefore we assessed; average walking speed, 139 
positive and negative peaks in sagittal plane joint moments and powers, peak flexion 140 
and extension at hips, knees and ankles (dorsi- and plantar-flexion) and the joint angle 141 
at specific gait events (e.g. initial contact, peak loading response, toe-off). Clinically 142 
meaningful differences in these biomechanical outcome variables were defined as those 143 
with an effect size difference (d) between prosthetic conditions of at least 0.4 (‘medium’ 144 
effect size)11. No inferential statistical tests were applied.  145 
 146 
Results 147 
In total, there were eight biomechanical variables where clinically meaningful 148 
differences (d > 0.4) were evident between foot types during the first data collection 149 
session. These variables were walking speed, peak plantar- and dorsi-flexion at the 150 
prosthetic ‘ankle’, residual knee loading response flexion, peak positive power during 151 
early stance at the prosthetic ‘ankle’, peak negative residual knee power during late 152 
stance, and peak stance-phase extension and flexion moments at the residual knee 153 
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(direction and magnitude of differences are shown at Table 1 and Figures 1 and 2). The 154 
mean (SD) effect size difference between foot types was 0.99 (0.48). During the second 155 
data collection session, differences between foot types in the same eight variables were 156 
in the same direction and had much the same effect size, mean 0.89 (0.51), as those 157 
determined during the first session (Table 1).  158 
INSERT TABLE 1 159 
INSERT FIGURE 1  160 
INSERT FIGURE 2 161 
 162 
 163 
Discussion 164 
The aim of the current study was to investigate the efficacy of making decisions 165 
regarding prosthetic foot prescription for an individual patient, based on a single session 166 
comparison of their gait using two different foot-ankle devices. To fulfil this aim we 167 
undertook quantitative gait analyses of a an individual with a trans-tibial amputation, 168 
using two different foot-ankle devices, on two separate occasions 14 months apart. 169 
 170 
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The results indicated that eight biomechanical variables had ‘medium’ or ‘large’ 171 
effect size differences between prosthetic foot types (d > 0.4) during the first data 172 
collection session. All eight of these variables had the same directional and comparable 173 
effect size differences between prosthetic conditions during the second data collection 174 
session, which was conducted 14 months after the initial session with the participant 175 
now older and heavier by 6kg, indicating an increase in body mass index from 26.1 to 176 
27.9 (implying his physical conditioning had altered). The average effect size difference 177 
between prosthetic foot types was slightly greater in the first session than the second 178 
(session 1, d = 0.99; session 2, d = 0.89), although average effect sizes were similarly 179 
‘large’ for both data collection sessions. Therefore, these results suggest that a single 180 
session comparison of the gait of an individual with unilateral trans-tibial amputation 181 
using two different foot-ankle devices, as is typically undertaken in a clinical setting 182 
(albeit in a qualitative manner), is appropriate for identifying biomechanical differences 183 
between prosthetic devices. Hence it is a valid type of evaluation to conduct when 184 
finalising decisions about prosthetic prescription.  185 
 186 
Despite an increase in participant mass of 6kg between sessions, both feet had 187 
the same category of heel and forefoot keel stiffness on both occasions. With such an 188 
increase in body mass, absolute joint kinetic values would have increased between 189 
testing sessions, so in order to ensure comparisons were valid all joint kinetic 190 
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parameters were normalised to body mass. These normalised values, which had 191 
comparable magnitudes between sessions, showed meaningful effect size differences 192 
between prosthetic foot types in both data collection sessions; suggesting the change in 193 
foot type was the main cause of such differences, not patient-related factors. These 194 
findings support our stated supposition. 195 
 196 
Self-selected walking speed was higher during both sessions (‘medium’ effect 197 
sizes) when the participant used the Elan, compared to the Epirus foot device. Increased 198 
self-selected walking speed can be considered a global descriptor of improved gait 199 
function.12 Thus speed increases when using a particular foot device provide an 200 
indication that any accompanying changes in other parameters when using the new 201 
device may also be beneficial. Thus in the present study, the reduction in peak negative 202 
residual knee power during late stance when using the Elan compared to the Epirus foot 203 
device, for example, can be interpreted as a beneficial change. 204 
 205 
Generally, the magnitudes of effect size differences between prosthetic 206 
conditions appear to reflect relatively low inter-trial variability rather than large changes 207 
to average values (see Figures 1 and 2). This is likely due to the participant, who was 208 
assessed as being K4 on the Medicare scale, having excellent gait function. Whilst data  209 
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from such a participant may be limited in terms of its generalisibility to the wider 210 
population group, such a participant would be better able to adjust to using different, 211 
non-habitual feet than a participant with a lower level of function. It is quite possible 212 
that the differences between prosthetic conditions observed in the present study may 213 
well be amplified in an individual with a lower Medicare classification due to them 214 
being more affected by the function and/or design features of a particular prosthetic 215 
device, compared to an individual with higher levels of function.  216 
 217 
In conclusion, the findings of this study indicate that the direction and effect 218 
sizes of differences in biomechanical outcomes when using one prosthetic foot versus 219 
another remained more or less constant when such assessment was conducted 14 220 
months later, even though certain participant specific parameters (e.g. body mass, age) 221 
were different between sessions. These findings support our stated (a priori) 222 
supposition and lends support to the current clinical practice of finalising decisions 223 
regarding prosthetic prescription for an individual, based on a single session comparison 224 
of their gait using two different devices (typically, new device compared to habitual 225 
device). Potentially, future studies could undertake a case-series using the same 226 
approach as the present study to support, or refute, the findings of this study.  227 
  228 
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Figure 1 Mean (SD) sagittal plane angular displacement at the prosthetic ‘ankle’ (top) 283 
and residual knee (bottom) using Elan (dashed lines) and Epirus (solid lines) foot 284 
devices. Data collection session one is on the left and session two on the right. 285 
 286 
Figure 2 Mean (SD) sagittal plane prosthetic ‘ankle’ joint rotation power (top; power 287 
generation is positive, absorbtion is negative) and residual knee joint moment (bottom; 288 
internal extension moment is positive, flexion moment is negative) using Elan (dashed 289 
lines) and Epirus (solid lines) foot devices. Data collection session one is on the left and 290 
session two on the right. 291 
 292 
Table 1. A list of mean (SD) variables with clinically meaningful inter-foot differences.  293 
 294 
